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1. introduction 2. Materials and methods 
The variety of physiological effects attributed to 
estrogens, as well as the pathological characteristics of 
estrogen-sensitive human breast umors, have prompted 
numerous tudies on the possible metabolic onver- 
sion of the parent estrogens to activated metabolites. 
Most of these efforts have focused on the formation 
and properties of the catecholestrogens of El and E?. 
The enzyme system catalyzing their synthesis i  a 
cytochrome WSOdependent monooxygenase localized 
primarily in liver, but also found in numerous 
estrogen-sensitive mammalian tissues [1,2] including 
human mammary neoplasma [3]. 
Little information is available on the substrate 
specificity of this microsomal enzyme system. It is 
usually described as an estrogen 2-hydroxylase, since 
derivatives of 2-OHE, and 2-OHEa are the principal 
products identified from incubations of El and Ez, 
respectively, with microsomes from rat tissues [4,7]. 
The objective of this study was to determine if differ- 
ences in the structure of estrogens ofmajor therapeutic 
interest would significantly affect the relative rates of 
formation of their 2- and 4-hydroxy metabolites. Evi- 
dence was also sought for the biosynthesis of cate- 
cholestrogens by microsomes from a cultured line of 
human mammary tumor cells whose growth was 
known to be stimulated by these hormones [2]. 
Moxestrol, the 2- and 4-hydroxy derivatives of
moxestrol [8] and ethynylestradiol were generously 
provided by Drs J. P. Raynaud and G. Deltour 
(Roussel-UCLAF, Romainville). The method in [9] 
was used for the synthesis of 4.hydroxyequilenin. 
Other catecholestrogens and their monomethyl ethers 
were obtained from Steraloids (Wilton NH) or pre- 
pared by established procedures [ 11. Hepes, NADPH 
and Lascorbic acid were purchased from Sigma (St 
Louis MD). [ 3H] SAM (13.5 Ci/mmol) was obtained 
from New England Nuclear (Boston MA). Spectro- 
analyzed grade dimethylsulfoxide and HPLC grade 
n-heptane were from Fisher Scientific (Fair Lawn NJ) 
and USPgrade absolute thanol was from US Industrial 
Chemicals (New York NY). 
Abbreviations and trivial names: estrone, E,; 2-hydroxy- 
estrone, 2XIHE,;4hydroxyestrone, 4KIHE,; estradiol-170, 
E,; 2_hydroxyestradiol-17p, 2-OHE,; 4-hydroxyestradiol-17p, 
4-OHE,; lip-methoxy-17orethynyl-1,3,5-(lO)estratriene- 
3,17pdiol, moxestrol; lip-methoxy-17aethynyl-1,3,5(10)- 
estratriene_2,3,17@triol, 2-OHmoxestrol; S-(methyl-“HI- 
adenosyl-L-methionine, [ 3H] SAM; high-performance liquid 
chromatography, HPLC 
Radioenzymatic assay: The preparation of catechol- 
O-methyltransferase (EC 2.1 .1.6) and the microsomal 
fractions has been described [S]. Washed microsomes 
from the livers of adult female baboons were stored 
at -80°C in 0.25 M sucrose at 30 mg microsomal 
protein/ml with no loss of activity for at least 1 year. 
Prior to assay, they were thawed and diluted with 
10 mM Hepes buffer (PH 7.4) at 0-4’C. Microsomes 
from MCF-7 cells [3] were resuspended in this buffer 
and used within 2 h. Incubations were performed 
using slight modifications of the procedure in [5]. 
The incubation mixtures were prepared at 04°C and 
consisted of the following: 300 j,d of 10 mM Hepes 
buffer (pH 7.4) containing 50-500 pg microsomal 
protein and 22.5 nmol estrogen (in 1 r.d dimethyl- 
sulfoxide), 15 d [‘HI SAM (7.5 &i), 30 4 partially 
purified catechol-O-methyltransferase (333units), 
25 d freshly prepared 6mM Lascorbic acid, and 
30 fi 1 M MgClz in 400 /.d. The incubation mixtures 
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were then placed in a shaking water bath at 37’C for 
5 min. The enzymatic reaction was initiated by the 
addition of 50 r_l1 of 18 mM NADPH. Blanks consisted 
of incubation mixtures lacking substrate or contain- 
ing heat-treated microsomes including substrate, and 
were not significantly different from each other. 
Aliquots (80 4) were withdrawn at time 0 and at 
2 S min intervals for 10 min and added to 1 .O ml 0.05 M 
borate buffer (pH 10) containing arecovery standard 
(40 000 dpm) of 14C-labeled 2.methoxyestradiol. A 
mixture of unlabeled 2. and 4.methoxy derivatives of
Er and Ez (10 pg each) was added to provide chro- 
matographic markers. The radioactive monomethyl 
ethers were extracted into 6 ml n-heptane and the 
radioactivity in 0.5 ml aliquots of the extracts was 
measured [5]. The total dpm of 3H-labeled mono- 
methyl ethers formed in the reactions was corrected 
for the recovery of 14C-labeled 2.methoxyestradiol 
which averaged -85%. (Use of the 7 other 14C-labeled 
monomethyl ethers of the catecholestrogens of Er or 
Ez shown in fig.2 yielded a similar 83-87% recovery.) 
The remainder of the heptane xtracts was evaporated 
under .N2 and dissolved in 50 4 dichloromethane for 
analysis by HPLC. 
HPLC was performed using an automated gradient 
system (Model 273, Waters Assoc., Milford MA) 
equipped with system controller (model 720), sample 
processor (WISP model 7 1 OB), data module (model 
730), a 280 nm W detector (model 1203, Lab. Data 
Control, Riviera Beach FL), and a fraction collector 
(MultiRac, model 2111, LKES, Rockville MD). A 
0.46 X 50 cm Chromegabond Diol column (E. S. 
Industries, Marlton NJ) was equilibrated with 1.25% 
ethanol in n-heptane. All flow rates were 2 ml/min. 
After injection of the sample in 50 /.d dichloromethane 
the column was developed using a linear gradient of 
1.25-8.75% ethanol in n-heptane over 1 h. Fractions 
of the eluate were collected at 0.5 min intervals and 
used for determination of radioactivity. The column 
was washed for 15 min with absolute thanol and 
re-equilibrated for 15 min with 1.25% ethanol in 
n-heptane prior to injection of the next sample. 
Standard curves were prepared by dissolving 
authentic atecholestrogens i  dimethylsulfoxide, 
diluting to the appropriate concentration i  150 4 
cold Hepes buffer, and incubating in the absence of 
microsomes and NADPH [lo]. A recovery standard 
of 14C-labeled 2-methoxyestradiol was used to correct 
for losses during extraction and chromatography. 
3. Results and discussion 
Monomethyl ether derivatization [lo] of the 
catecholestrogens produced by microsomes has 
been used to prevent heir further A ring oxidation 
and irreversible binding to microsomal protein [ 11. 
HPLC separated the different pairs of monoethyl 
ether derivatives of the individual 2- and 4.hydroxy- 
estrogens [ 1 ] and eliminated interfering products. 
Fig.1 demonstrates that similar yields were obtained 
for the linear formation of the 3H-labeled monomethyl 
ethers of 2.OHEr, 2.OHEz, 4.OHEr, 4-OHEz, and 
2.OHmoxestrol. These results are in accord with the 
established substrate specificity of rat liver catechol- 
O-methyltransferase [ 111. The separation of these 
monomethyl ethers by HPLC is shown in fig.2. The 
resolution of peaks I-IV and peaks V-VIII allows 
the simultaneous measurement of the relative rates 
of formation of the catecholestrogens from Er or 
Ez. Peak IX is an unresolved mixture of the 2- and 
3.monomethyl ethers of 2.OHmoxestrol which has 
been included as an internal standard. Aliquots 
(8_3%)of the blanks before HPLC averaged 400 dpm. 
After HPLC of the remainder of the extracts of the 
blanks, the total amount of tritium in the areas of the 
individual monomethyl ethers (fig.2) averaged only 
-120 dpm. 
The formation of 2. and 4-hydroxyestrogen 
monomethyl ethers from separate incubations of El 
np CATECHOLESTROGEN 
Fig.1. Standard curves for the radioenzymatic assay of cate- 
cholestrogens. The total ‘H dpm of the monomethyl ethers 
obtained after HPLC and correction for recovery (av. 85%) 
is shown as a function of ng catecholestrogen used in the 
assay. 
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or Ez with microsomes from baboon liver and from 
cultured MCF-7 cells is illustrated in fig.2. The pre- 
dominance of the ‘H-labeled monomethyl ethers 
of 2-OHEI (90%) and 2-OHEz (93%) with these 
primate microsomes i similar to results obtained 
3 
1 MCF-7Cd1 Mtcrosomes 1 
0 IO 20 30 40 50 60 
0 IO 20 30 40 50 60 
TIME (min) 
Fig.2. Separation f the monomethyl ethers of catechol- 
estrogens by HPLC. In the lower curve the authentic 
2-methoxy (2-MeO),clmethoxy (4-MeO), or 3-methyl(3-ME) 
monomethyl ethers of the catecholestrogens shown in fig.1 
were used. The two upper curves are chromatograms of the 
products of the assay of baboon liver microsomes (50 pg pro- 
tein) and MCF-7 cell microsomes (500 wg protein) using 
50 PM E, (o-o) and E, (o-o) as substrates, and an 
internal standard of Z-OHmoxestrol (X-X). The relative 
retention times for the labeled and unlabeled monomethyl 
ethers were identical. 
with rat liver microsomes [5-71. An 87% average 
recovery of the 3H-labeled monomethyl ethers was 
obtained when 5 ng of the authentic 2- and 4-hydroxy 
metabolites of El and Ez (fig.1) were added to these 
incubations, demonstrating that there is not a selec- 
tive depletion of the 4-hydroxy products by other 
pathways. The yield (fig.2) of 4-OHE1 and 4-OHEz 
increased from 10% and 6%, respectively, with hepatic 
microsomes, to 28% and 14%, respectively, with the 
MCF-7 cell microsomes. Thus, the proportion of 
4.hydroxyestrogen formation was nearly 3 times 
greater with microsomes from MCF-7 cells than with 
hepatic microsomes. 
The relative rates of total catecholestrogen forma- 
tion from 6 different estrogen substrates by baboon 
liver microsomes are shown in fig.3. A yield of 
40 pmol total product (12 X 10’ dpm 3H) represents 
a 40% yield from [3H] SAM but only a 1% yield from 
the unlabeled estrogen substrate which is present in 
saturating concentration i  these assays. Ethynyl- 
estradiol was the most active substrate, and a linear 
rate was obtained with a 20.fold reduction in micro- 
somal protein (not shown). With moxestrol, there 
was a 40-fold reduction in the initial rate of total 
catecholestrogen formation compared to ethynyl- 
estradiol due to a marked inhibition of 2-hydroxy- 
estrogen synthesis by the neighboring 1l/3-methoxy 
group of this potent estrogen. The relative rate of 
catecholestrogen formation with El, which was 62% 
of the rate with Ez, was the same as that reported for 
Lo 
b SUBSTRATE 
ETHWYL- 
INCUBATION TIME (MINI 
Fig.3. Radioenzymatic assay of 50 PM estrogens with baboon 
liver microsomes (50 pg protein). The total pmol and ‘H dpm 
of the monomethyl ethers obtained in the heptane extracts 
after correction for recovery is shown as a function of incu- 
bation time (min). 
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Table 1 
Catecholestrogen formation by baboon liver microsomes 
Substrate 
- 
Ethynylestradiol 
Estradiol 
Equilenin 
Equilin 
Estrone 
Moxestrol 
Method of % [aH]Monomethyl ethers of Average ratio 
analysis 2_OH:4_OH product 
2XIH Product 4-OH Product 
A 93.2-95.4 4.5- 5.2 2O:l 
A 92.1-95.4 4.3- 1.5 16:l 
B - 76.1-81.4 <0.3:1 
C 67.1-69.7 27.5-29.0 2.4:1 
A 88.0-91.1 8.0-12.1 9:l 
A 68.9-71.3 25.9-28.6 2.5:1 
Substrates (50 PM) were incubated for 10 mm with baboon liver microsomes (50 pg protein). The 
results are shown for the range of 3 different incubations as analyzed (A) by comparison with reten- 
tion times of authentic standards, (B) by comparison with retention times of monomethyl ethers 
obtained from incubation of 4hydroxyequilenin with catecholO-methyltransferase and (“HISAM, 
and (C) by comparison with the retention times of authentic monomethyl ethers of 2-OHE, and 
4_OHE,. The double bond in ring B of the equilin series caused a uniform 2 min increase in retention 
time over that of the analogous estrane 
rat liver microsomes [6]. The rates with the 17-keto 
equine estrogens equilin and equilenin were greater 
than the rate with El. 
The relative ratios of 2- to 4-hydroxyestrogen 
formation from these 6 estrogen substrates are shown 
in table 1. A 20: 1 ratio was obtained with ethynyl- 
estradiol and a 16: 1 ratio with Ez. This ratio decreased 
with structural alterations in ring D (E,, 9 : 1) and ring 
C (moxestrol, 2.5 : 1). The above changes in the ratio 
of catecholestrogen products parallel the relative rates 
reaction shown in Iig.2. However, this generalization 
does not apply for all substrates. Comparison of 
results with El and equihn shows that the unconjugated 
double bond in ring B of equilin resulted in an -3.fold 
increase in the amount of 4-hydroxyequilin forma- 
tion compared to 4-OHEi formed from Ei. In the 
case of equilenin, where rings A and B are both 
aromatic, the major catecholestrogen formed was the 
4-hydroxy product in 78% average yield. Structural 
alterations of estrogens in the B and C rings can 
therefore markedly alter the relative ratio of 2- and 
4-hydroxyestrogen synthesis by hepatic microsomes. 
This is further illustrated by results with 1 lp-ethyl- 
estradiol (not shown) where a 1.9: 1 ratio was obtained 
us the 16: 1 ratio with Ez (table 1). 
These data show that the relative rates of forma- 
tion of 2- and 4-hydroxyestrogens depend not only 
on the source of the microsomal activating system, 
but also on the estrogen substrate. This finding would 
have important consequences where there is a signiti- 
cant difference in the biological effects produced by 
2- and 4-hydroxyestrogens [ 12-141. 
Since estrogen binding to the estrogen receptor 
of human breast umor cells is being extensively 
investigated in other laboratories, it is noteworthy 
that microsomes from continuously cultured MCF-7 
cells showed a significant rate of formation of cate- 
cholestrogens. Microsomes from samples of normal 
breast issue are devoid of this activity [3]. Many 
human breast umors are also capable of forming El 
and Er from androstenedione and testosterone in
vitro, including cultured MCF-7 cells [ 151. Markedly 
elevated levels of 2-OHEz have been found in the 
urine of some patients with breast cancer; these 
decrease to very low levels several days after removal 
of the tumors (S. L. Cohen and P. Ho, personal com- 
munication). 2-OHEr stimulates the growth of MCF-7 
cells and binds to the estrogen receptor [2]. The 
clinical significance of the estrogen-responsive br ast 
tumor as a paraendocrine organ [ 161 has not yet been 
established. 
In a study of the neoplastic transformation of 
Balb/c 3T3 cells by Er and ethynylestradiol, we 
found that microsomes from these mouse fibroblast 
cells also catalyzed the formation of catecholestrogens 
from these substrates [ 171. In contrast, moxestrol did 
not induce transformation of these cells and was also 
a poor substrate for microsomal oxidation, in agree- 
ment with the data obtained with hepatic microsomes 
(fig.2). These results are consistent with the mecha- 
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nism that has been proposed for isomeric 1,2- and 
4,Sepoxides of Ez as intermediates in the formation 
of catecholestrogens and as transforming agents [181. 
By analogy with the metabolism of carcinogenic 
polycyclic aromatic hydrocarbons, the relative rates 
of formation of such intermediates would be expected 
to depend on both the tissue from which the micro- 
somes were derived, and also on functional groups of 
the estrogen substrate which could influence this type 
of metabolic activation. 
Acknowledgements 
This investigation issupported by grant CA24629, 
awarded by the National Cancer Institute, DHEW. We 
are indebted to the Joe and Jessie Crump Fund of 
Fort Worth, Texas, for donating the HPLC equipment. 
Our thanks go to Dr William L. McGuire for providing 
the MCF-7 cells and to Alfred C. Bodenman for cul- 
turing them in our laboratory. 
References 
[l] Ball, P. and Knuppen, R. (1980) Acta Endocrinol. 93, 
suppl. 232,1-127. 
[2] Paul, S. M., Hoffman, A. R. and Axehod, J. (1980) 
Front. Neuroendocrinol. 6,203-217. 
[3] Hoffman, A. R., Paul, S. M. and Axelrod, J. (1979) 
Cancer Res. 39,4584-4587. 
[4] Fishman, J. and Norton, B. (1975) Endocrinology 96, 
1054-1059. 
[5] Paul, S. M., Axelrod. J. and Diliberto, E. J. jr (1977) 
Endocrinology 101,1604-1610. 
[6] Barbieri, R. L.,Canick, J. A. and Ryan, K. J. (1978) 
Steroids 32,529-538. 
[7] Hoffman, A. R., Paul, S. M. and Axelrod, J. (1980) 
Biochem. Pharmacol. 29,83-87. 
[8] Salmon, J., Coussediere, D., Cousty, C., DeLaRoff, V. 
and Raynaud, J. P. (1979) Steroids 34,381-400. 
[9] Teuber, H.-J. (1953) Chem. Ber. 86,1495-1499. 
[lo] Paul, S. M. and Axelrod, J. (1977) Life Sci. 21, 
493-502. 
[ 111 Merriam, G. R., MacLusky, N. J., Picard, M. K. and 
Naftolin,F. (1980) Steroids 36, l-11. 
[ 121 Franks, S., Ball, P., Naftolin, F. and Ruf, K. B. (1980) 
J. Endocrinol. 86,263-268. 
[ 131 Ball, P., Emons, G. and Gethmann, U. (1981) Acta 
Endocrinol. 96,470-474. 
[14] Kelly, R. W. and Abel, M. H. (1981) J. Steroid Bio- 
them. 14,787-791. 
[ 151 Ma&doe, J. H. (1979) J. Clin. Endocrinol. Metab. 
49,272-277. 
(161 Adams, J. B. and Wong, M. S. F. (1968) J. Endocrinol. 
41,41-52. 
[ 171 Purdy, R. H., Weiss, S. A., Durocher, C. K. and Rhim, 
J. S. (1981) Proc. Am. Assoc. Cancer Res. 22,5(17). 
[ 181 Le Quesne, P. W., Durga, A. V., Subramanyam, V., 
Soloway, A. H., Hart, R. W. and Purdy, R. H. (1980) J. 
Med. Chem. 23,239-240. 
44 
